Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -3.14% is 115% below its 5-year average of 20.42%, near the low end of its 5-year range (-6.44%–83.78%).
As of the fiscal period ended Wednesday, December 31, 2025. 34.45% above its 12-month average of -4.79%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
-3.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-4.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
9.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
20.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+34.45%
CURRENT VS 3Y AVG
-132.87%
CURRENT VS 5Y AVG
-115.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-136.81%
vs the sector median at left
BioNTech SE
Market Cap
$22.59B
Return on Invested Capital (ROIC)
-3.14%
TTM Avg
-4.79%
3Y Avg
9.55%
5Y Avg
20.42%
Market Cap
$22.43B
Return on Invested Capital (ROIC)
16.13%
TTM Avg
15.79%
3Y Avg
14.56%
5Y Avg
13.09%
Market Cap
$23.10B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
14.65%
3Y Avg
16.90%
5Y Avg
17.70%
Market Cap
$23.51B
Return on Invested Capital (ROIC)
20.58%
TTM Avg
10.42%
3Y Avg
9.36%
5Y Avg
7.13%
Market Cap
$21.45B
Return on Invested Capital (ROIC)
-29.70%
TTM Avg
-31.12%
3Y Avg
-12.69%
5Y Avg
0.19%
Market Cap
$20.86B
Return on Invested Capital (ROIC)
8.47%
TTM Avg
7.82%
3Y Avg
7.13%
5Y Avg
6.49%
Market Cap
$24.34B
Return on Invested Capital (ROIC)
7.39%
TTM Avg
6.30%
3Y Avg
5.64%
5Y Avg
7.56%
Market Cap
$24.42B
Return on Invested Capital (ROIC)
17.57%
TTM Avg
18.00%
3Y Avg
20.73%
5Y Avg
22.79%
Market Cap
$20.08B
Return on Invested Capital (ROIC)
-7.95%
TTM Avg
-3.96%
3Y Avg
-1.19%
5Y Avg
-0.87%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $22.59B | -3.14% | -4.79% | 9.55% | 20.42% |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | 16.13% | 15.79% | 14.56% | 13.09% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 13.62% | 14.65% | 16.90% | 17.70% |
| Incyte Corporation (INCY)vs › | $23.51B | 20.58% | 10.42% | 9.36% | 7.13% |
| Moderna, Inc. (MRNA)vs › | $21.45B | -29.70% | -31.12% | -12.69% | 0.19% |
| STERIS plc (STE)vs › | $20.86B | 8.47% | 7.82% | 7.13% | 6.49% |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 7.39% | 6.30% | 5.64% | 7.56% |
| Waters Corporation (WAT)vs › | $24.42B | 17.57% | 18.00% | 20.73% | 22.79% |
| Viatris Inc. (VTRS)vs › | $20.08B | -7.95% | -3.96% | -1.19% | -0.87% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 8.43% | 7.70% | 8.24% | 10.04% |
ROIC
-3.1%
ROE
-6.8%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -3.14% |
| 2024-12-31 | -6.44% |
| 2023-12-31 | 2.58% |
| 2022-12-31 | 45.21% |
| 2021-12-31 | 83.78% |
| 2020-12-31 | 0.50% |
| 2019-12-31 | -27.27% |
| 2018-12-31 | -10.22% |
| 2017-12-31 | -28.35% |
| 2016-12-31 | 0.00% |
